Showing 34,870 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP

PrEP in England

Editor's pick
BBC Radio 4 (audio)
9 February 2018
PrEP

As PrEP Use Soars Among Men in California, Racial Disparities Persist

Editor's pick
Poz
9 February 2018
Epidemiology & behaviour

National Black HIV/AIDS Awareness Day: Recognizing Our Resilience

Editor's pick
AIDS United
8 February 2018
New & experimental HIV treatments

US regulators approve new HIV combo pill containing bictegravir

News
8 February 2018
New & experimental HIV treatments

ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment

Editor's pick
ViiV press release
8 February 2018
New & experimental HIV treatments

US FDA approves Gilead triple HIV drug, rival files lawsuit

Editor's pick
Reuters
8 February 2018
Exposure to HIV through medical procedures

Indian police arrest 'doctor' accused of spreading HIV

Editor's pick
The Guardian
7 February 2018
Neurological & cognitive problems

Marijuana may help HIV patients keep mental stamina longer

Editor's pick
Michigan State University
7 February 2018
PrEP

Australia: Breakthrough drug PrEP to be approved for public subsidy

Editor's pick
The Sydney Morning Herald
7 February 2018
Cancer

HPV Vaccine For Gay And Bisexual Men Is Long Overdue But It’s Not Enough To Protect Everyone From Preventable Cancers

Editor's pick
Huffington Post
7 February 2018
Harm reduction

Facebook Is Deleting Valuable Drug Harm Reduction Groups

Editor's pick
Vice
7 February 2018
The search for a cure

Case Western Reserve and Sangamo Therapeutics Announce $11 Million NIH Grant for Study of Gene-Edited T Cells for Viral Eradication of HIV

Editor's pick
Sangamo press release
7 February 2018
Pharmaceutical industry

Janssen HIV Drug U.K. Patent Extension Case to Go to EU Top Court

Editor's pick
Bloomberg
7 February 2018
Generic medicines

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

News
7 February 2018
Harm reduction

Ukraine Expands Opioid Substitution Therapy to Reduce HIV

Editor's pick
Talking Drugs
7 February 2018
PrEP

HIV prevention drug Truvada to be publicly funded in New Zealand

Editor's pick
TV NZ
7 February 2018
PrEP

VICTORY: Publix Reverses Stance. Will Make PrEP Available To Employees

Editor's pick
Equality Florida
7 February 2018
Hepatitis B

'Virus-cracking' molecules advance fight against hepatitis B

Editor's pick
Science Daily
7 February 2018
Exposure to HIV through medical procedures

India officials investigate if fake doctor spread HIV

Editor's pick
BBC News
7 February 2018
Sexually transmitted infections prevention

Gonorrhea in China shows waning susceptibility to WHO-recommended antibiotics

Editor's pick
Eurekalert Inf Dis
7 February 2018
Harm reduction

SF safe injection sites expected to be first in nation, open around July 1

Editor's pick
San Francisco Chronicle
6 February 2018
Condoms & lubricant

Will Americans Ever Actually Use the Female Condom?

Editor's pick
Vice
6 February 2018
Contraception

Reproductive health of HIV-positive women in Switzerland being neglected, says study

News
6 February 2018
Cardiovascular disease

1 in 8 patients with HIV has undiagnosed hypertension

Editor's pick
Healio
6 February 2018